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Patient Experience with 
Imiquimod for Extramammary 
Paget’s Disease
Darren D’Mello, Paul H. Chung, MD*
Introduction
• Imiquimod is a topical medication that induces cytokines and modifies the 
innate immune response.
• It is used to treat many dermatologic conditions such as genital warts, 
superficial basal cell carcinoma, and actinic keratosis1. It has also been used 
to treat patients with Extra-Mammary Paget’s Disease (EMPD). 
• EMPD is a condition that presents as erythematous plaques that can 
progressively invade deep into the skin layers. It usually presents on the 
vulva, but perianal, penile, scrotal, and perineal skin are affected in some 
cases2. 
Cont.
• Usually, EMPD is treated with surgery (skin graft, MMS) and sometimes 
with chemotherapy and other types of treatment. Imiquimod has been 
used in some cases but is being used more and more.
• There have been case reports that described the effects and outcomes of 
patients who were treated with Imiquimod, but more research on its use 
for EMPD must be done. Much of these reports were created by the 
physicians reporting on their own patients, so sample sizes were small
• There have been no studies that gathered data from the patients 
themselves; this is what our study hopes to accomplish. 
Objectives and Hypothesis
• The purpose of the study is to gather information from  patients who 
currently or previously had EMPD
• Some of the information that will be gathered includes:
• Demographic information
• Diagnostic information
• When were they diagnosed, which kind of provider diagnosed them
• Treatment information
• Which treatments have they had, have they used imiquimod, side effects of the 
imiquimod, specific regimen used
• Outcome information
• What is the current status of the disease, was imiquimod effective by itself or 
with combination
Objectives and Hypothesis
• We hypothesize that patients with EMPD who were treated with 
Imiquimod early after their diagnoses or after surgery had better 
outcomes than those who did not use Imiquimod at all. 
• Our hypothesis may or may not be correct, but any information gathered 
will be novel and help further the information known about this 
treatment option for patients with EMPD
Approach/Methods
• This study is a case series as we are asking patients who already have a 
particular disease to provide information
• Our patient pool is from a patient support group for EMPD
• A questionnaire made using Qualtrics will be sent to these patients
• this questionnaire was created by us but was looked over by a dermatologist and an 
EMPD patient who is part of the support group in order to assess the relevance of the 
questions 
• While data will come from the questionnaire, we also want to create a 
literature review of the many case reports of patients with EMPD treated 
with Imiquimod. 
• This involved the collecting all the papers reporting the use of the medicine in patients 
with the disease, and then formatting the information into a table that can be added 
into our paper  

Current and Future Plans 
• As of now, I am completing the IRB forms necessary before sending out 
the questionnaire. 
• Once submitted, we are hoping to finish all edits on the questionnaire so 
that it can be sent out as soon as the IRB is approved.
• Once we get the data from the questionnaire back, we will analyze it and 
look for any trends. 
• This data will be reported in our paper
• Project should be complete around Fall this year.
Implications and Conclusion
• Considering how rare EMPD is, novel research on the disease and the 
treatments for it is not substantial
• This is especially true of Imiquimod based treatment plans
• The case reports that have been made about it have shown promising results, but 
samples are small 
• A study based on the patient’s perspective of treatment for EMPD with 
Imiquimod would be a new way to look at how this treatment affects the 
patients when it comes to factors like efficacy, side effects, etc.
• Including the review of the case reports will make it easy for future readers to see the 
other reports on the topic
• Our hope is that future research builds upon our study so that eventually 
evidence-based guidelines on treating EMPD with Imiquimod will make it 
easier for physicians to treat patients and improve outcomes for patients 
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